Copyright
©2014 Baishideng Publishing Group Inc.
World J Diabetes. Dec 15, 2014; 5(6): 763-776
Published online Dec 15, 2014. doi: 10.4239/wjd.v5.i6.763
Published online Dec 15, 2014. doi: 10.4239/wjd.v5.i6.763
Figure 1 Biomarkers for diabetic nephropathy.
NGAL: Neutrophil gelatinase associated lipocalin; KIM1: Kidney injury molecule 1; NAG: N-acetyl-b-d-glucosaminidase; L-FABP: Liver-type fatty acid binding protein; RBP: Retinol binding protein; 8-OHdG: 8-oxo-7,8-dihydro-2’-deoxyguanosine; AGA: α-1-acid glycoprotein; TNFAR 1/2: Tumor necrosis factors-α receptors 1 and 2; IL-6: Interleukin-6; VEGF: Vascular endothelial growth factor.
- Citation: Currie G, McKay G, Delles C. Biomarkers in diabetic nephropathy: Present and future. World J Diabetes 2014; 5(6): 763-776
- URL: https://www.wjgnet.com/1948-9358/full/v5/i6/763.htm
- DOI: https://dx.doi.org/10.4239/wjd.v5.i6.763